Philippine Congress Agrees DOH To Have Drug Price-Regulation Authority
This article was originally published in PharmAsia News
Executive Summary
House and Senate negotiators resolving conflicting versions of The Philippines' Quality and Affordable Medicines Bill have agreed the Department of Health is to oversee and regulate the prices of drugs. The conference committee failed to reach agreement on a disputed provision in one version of the bill that instructs physicians to write prescriptions only for generic drugs. Otherwise, one of the leaders said 90 percent of the bill has been completed. The DOH was given price-regulation authority because committee members believed it had the necessary expertise. The bills as passed by each house would have put that authority in the Office of the President or create a price-setting board. (Click here for more
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.